This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/4/893    most recent 01.ATV.0000259365.31469.89v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mor, A. Articles by George, J. Search for Related Content PubMed PubMed Citation Articles by Mor, A. Articles by George, J. Pubmed/NCBI databases Substance via MeSH

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:893.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Role of Naturally Occurring CD4⁺CD25⁺ Regulatory T Cells in Experimental Atherosclerosis

Adi Mor; David Planer; Galia Luboshits; Arnon Afek; Shula Metzger; Tova Chajek-Shaul; Gad Keren; Jacob George

From the Department of Cardiology (A.M., G.L., A.A., G.K., J.G.), Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, and the Department of Medicine (D.P., S.M., T.C.-S.), Hadassah University Hospital, Mount Scopus, Israel.

Correspondence and reprint requests to Jacob George, MD, Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. E-mail jacobg{at}post.tau.ac.il

Objective— Naturally occurring CD4⁺CD25⁺ regulatory T cells (Tregs) exert suppressive effects on effector CD4 cells and downregulate experimental autoimmune disorders. We investigated the importance and potential role of Tregs in murine atherogenesis.

Methods and Results— Tregs were investigated comparatively between aged and young apolipoprotein E–knockout (ApoE-KO) mice and age-matched C57BL/6 littermates. The effect of oxidized LDL (oxLDL) was tested on the functional suppressive properties of Tregs from ApoE-KO and C57BL/6 mice. Tregs, CD4⁺CD25^– cells, and saline were infused into ApoE-KO mice to study their effects on atherogenesis. Treg numbers were reduced in atherosclerotic compared with nonatherosclerotic ApoE-KO mice. The functional suppressive properties of Tregs from ApoE-KO mice were compromised in comparison with those from their C57BL/6 littermates. Thus, oxLDL attenuated the suppressive properties of Tregs from C57BL/6 mice and more so in ApoE-KO mice. Transfer of Tregs from age-matched ApoE-KO mice resulted in significant attenuation of atherosclerosis compared with that after delivery of CD4⁺CD25^+/– T cells or phosphate-buffered saline.

Conclusions— CD4⁺CD25⁺ Tregs may play a protective role in the progression of atherosclerosis and could be considered a therapeutic tool if results from human studies can solidify observations in murine models.

Naturally occurring CD4⁺CD25⁺ regulatory T cells (Tregs) exert suppressive effects on effector CD4 cells and downregulate experimental autoimmune disorders. We investigated the importance and potential role of Tregs in murine atherogenesis. CD4⁺CD25⁺ Tregs may play a protective role in the progression of atherosclerosis and could be considered a therapeutic tool if results from human studies can solidify observations in murine models.

Key Words: atherosclerosis • T cells • immune response • adoptive transfer • foxp3

This article has been cited by other articles:

				J. Feng, Z. Zhang, W. Kong, B. Liu, Q. Xu, and X. Wang Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice Cardiovasc Res, October 1, 2009; 84(1): 155 - 163. [Abstract] [Full Text] [PDF]

				H. Kvakan, M. Kleinewietfeld, F. Qadri, J.-K. Park, R. Fischer, I. Schwarz, H.-P. Rahn, R. Plehm, M. Wellner, S. Elitok, et al. Regulatory T Cells Ameliorate Angiotensin II-Induced Cardiac Damage Circulation, June 9, 2009; 119(22): 2904 - 2912. [Abstract] [Full Text] [PDF]

				P. Meier, D. Golshayan, E. Blanc, M. Pascual, and M. Burnier Oxidized LDL Modulates Apoptosis of Regulatory T Cells in Patients with ESRD J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1368 - 1384. [Abstract] [Full Text] [PDF]

				Z. Mallat, S. Taleb, H. Ait-Oufella, and A. Tedgui The role of adaptive T cell immunity in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S364 - S369. [Abstract] [Full Text] [PDF]

				I. Gotsman, R. Gupta, and A. H. Lichtman The Influence of the Regulatory T Lymphocytes on Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2493 - 2495. [Full Text] [PDF]